Rapid measurement of inhibitor binding kinetics by isothermal titration calorimetry /631/45/607 /631/1647/2204 /631/92/613 /631/154 /9 article

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Di Trani, Justin M ^a   De Cesco, Stephane ^a   O'Leary, Rebecca ^a   Plescia, Jessica ^a   Do Nascimento, Claudia Jorge ^a,b   Moitessier, Nicolas ^a   Mittermaier, Anthony K ^a  

^a MCGILL UNIVERSITY   (Canada)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR; ENZYME INHIBITOR; SERINE PROTEINASE;

CALORIMETRY; CATALYSIS; CHEMICAL BINDING; DRUG DEVELOPMENT; ENZYME ACTIVITY; INHIBITION; INHIBITOR; REACTION KINETICS;

ARTICLE; BINDING KINETICS; DRUG PROTEIN BINDING; ISOTHERMAL TITRATION CALORIMETRY; BIOCATALYSIS; CALORIMETRY; CHEMISTRY; EVALUATION STUDY; KINETICS; PROCEDURES;

BIOCATALYSIS; CALORIMETRY; ENZYME INHIBITORS; KINETICS; SERINE ENDOPEPTIDASES;

EID: 85042878150     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-03263-3     Document Type: Article

References (34)

1. Lu, H. & Tonge, P. J. Drug-target residence time: critical information for lead optimization. Curr. Opin. Chem. Biol. 14, 467-474 (2010)
2. Markgren, P.-O. et al Relationships between structure and interaction kinetics for HIV-1 protease inhibitors. J. Med. Chem. 45, 5430-5439 (2002)
3. Copeland, R. A., Pompliano, D. L. & Meek, T. D. Drug-target residence time and its implications for lead optimization. Nat. Rev. Drug Discov. 5, 730-739 (2006)
4. Tummino, P. J. & Copeland, R. A. Residence time of receptor-ligand complexes and its effect on biological function. Biochemistry 47, 5481-5492 (2008)
5. Swinney, D. C. The role of binding kinetics in therapeutically useful drug action. Curr. Opin. Drug Discov. Dev. 12, 31-39 (2009)
6. Copeland, R. A. The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety. Expert Opin. Drug Dis. 5, 305-310 (2010)
7. Schloss, J. V. Significance of slow-binding enzyme inhibition and its relationship to reaction-intermediate analogs. Acc. Chem. Res. 21, 348-353 (1988)
8. Morrison, J. F. The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions. Trends Biochem. Sci. 7, 102-105 (1982)
9. Schneider, E. V., Böttcher, J., Huber, R., Maskos, K. & Neumann, L. Structure-kinetic relationship study of CDK8/CycC specific compounds. Proc. Natl Acad. Sci. USA 110, 8081-8086 (2013)
10. Vilums, M. et al. Structure-kinetic relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists. J. Med. Chem. 56, 7706-7714 (2013)
11. Tonge, P. J. Drug-target kinetics in drug discovery. ACS Chem. Neurosci. 9, 29-39 (2018)
12. Schwartz, P. A. et al. Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance. Proc. Natl Acad. Sci. USA 111, 173-178 (2014)
13. Copeland, R. A. Kinetics of single-substrate enzyme reactions (John Wiley & Sons, Inc., 2002)
14. Callan, O. H., So, O.-Y. & Swinney, D. C. The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen. J. Biol. Chem. 271, 3548-3554 (1996)
15. VenäLäInen Jarkko, I. et al. Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site. Biochem. J. 382, 1003-1008 (2004)
16. Todd, M. J. & Gomez, J. Enzyme kinetics determined using calorimetry: a general assay for enzyme activity? Anal. Biochem. 296, 179-187 (2001)
17. Olsen, S. N. Applications of isothermal titration calorimetry to measure enzyme kinetics and activity in complex solutions. Thermochim. Acta 448, 12-18 (2006)
18. Liang, Y. Applications of isothermal titration calorimetry in protein science. Acta Biochim. Biophys. Sin. 40, 565-576 (2008)
19. Lawandi, J., Gerber-Lemaire, S., Juillerat-Jeanneret, L. & Moitessier, N. Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors. J. Med. Chem. 53, 3423-3438 (2010)
20. Tanaka, S., Suzuki, K. & Sakaguchi, M. The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro. Breast Cancer 24, 658-666 (2017)
21. Singh, J., Petter, R. C., Baillie, T. A. & Whitty, A. The resurgence of covalent drugs. Nat. Rev. Drug Discov. 10, 307-317 (2011)
22. Robertson, J. G. Mechanistic basis of enzyme-targeted drugs. Biochemistry 44, 5561-5571 (2005)
23. De Cesco, S., Kurian, J., Dufresne, C., Mittermaier, A. K. & Moitessier, N. Covalent inhibitors design and discovery. Eur. J. Med. Chem. 138, 96-114 (2017)
24. Kuzmicˇ, P., Solowiej, J. & Murray, B. W. An algebraic model for the kinetics of covalent enzyme inhibition at low substrate concentrations. Anal. Biochem. 484, 82-90 (2015)
25. Strelow, J. M. A perspective on the kinetics of covalent and irreversible inhibition. SLAS Discov. 22, 3-20 (2016)
26. Kalwant, S. & Porter, A. G. Purification and characterization of human brain prolyl endopeptidase. Biochem. J. 276, 237-244 (1991)
27. Gabdoulline, R. R. & Wade, R. C. On the protein-protein diffusional encounter complex. J. Mol. Recognit. 12, 226-234 (1999)
28. Burnouf, D. et al. kinITC: a new method for obtaining joint thermodynamic and kinetic data by isothermal titration calorimetry. J. Am. Chem. Soc. 134, 559-565 (2012)
29. Vander Meulen, K. A. & Butcher, S. E. Characterization of the kinetic and thermodynamic landscape of RNA folding using a novel application of isothermal titration calorimetry. Nucleic Acids Res. 40, 2140-2151 (2012)
30. Di Trani, J. M., Moitessier, N. & Mittermaier, A. K. Measuring rapid time-scale reaction kinetics using isothermal titration calorimetry. Anal. Chem. 89, 7022-7030 (2017)
31. Turnbull, W. B. & Daranas, A. H. On the value of c: can low affinity systems be studied by isothermal titration calorimetry? J. Am. Chem. Soc. 125, 14859-14866 (2003)
32. Velazquez-Campoy, A. & Freire, E. Isothermal titration calorimetry to determine association constants for high-affinity ligands. Nat. Protoc. 1, 186-191 (2006)
33. Mariaule, G. et al. 3-Oxo-hexahydro-1H-isoindole-4-carboxylic acid as a drug chiral bicyclic scaffold: structure-based design and preparation of conformationally constrained covalent and noncovalent prolyl oligopeptidase inhibitors. J. Med. Chem. 59, 4221-4234 (2016)
34. Bakker, A. V., Jung, S., Spencer, R. W., Vinick, F. J. & Faraci, W. S. Slow tight-binding inhibition of prolyl endopeptidase by benzyloxycarbonyl-prolyl-prolinal. Biochem. J. 271, 559-562 (1990).